| BSE: 524414 | Sector: Others |
| NSE: N.A. | ISIN Code: INE744C01029 |
| BSE 00:00 | 11 Sep | 6.75 |
0 (0.00%) |
OPEN
6.75 |
HIGH
6.75 |
LOW
6.75 |
| NSE 05:30 | 01 Jan | Norris Medicines Ltd |
| OPEN | 6.75 |
| PREVIOUS CLOSE | 6.75 |
| VOLUME | 90 |
| 52-Week high | 10.61 |
| 52-Week low | 3.38 |
| P/E | |
| Mkt Cap.(Rs cr) | 7 |
| Buy Price | 7.10 |
| Buy Qty | 40.00 |
| Sell Price | 7.10 |
| Sell Qty | 20.00 |
Incorporated on 7 Sep.'90 as a private limited company and promoted by B N Thakore, N J Patel and N L Upadhyaya, Norris Medicines is purely a pharmaceutical formulations-based company. It became a public limited company in Mar.'92. Commercial production of the formulation unit commenced in Nov.'91. The company came out with a public issue aggregating Rs 5 cr in Dec.'93 to expand its existing ca...> More
| COMPANY INFORMATION | |||||||
| Managing Director : | Vimal D Shah | ||||||
| Independent Director : | Sanjiv Kumar Shah | ||||||
| Independent Director : | Hiten Parikh | ||||||
| Company Secretary : | Vinay Rana | ||||||
| AUDITOR : | H N Jadav & Co | ||||||
| IND NAME : | Trading | ||||||
| HOUSE NAME : | Indian Private | ||||||
| Registered office | |||||||
| Plot No 801/P & 802, GIDC Industrial Estate,Ankleshwar,Gujarat-393002 | |||||||
| Ph : 91-2646-223462/227530 | |||||||
| WEBSITE : http://www.norrispharma.com | |||||||
| E-mail : secretarial@norrispharma.com | |||||||
